@article{6520c9b9842447e28034ee4c539076d0,
title = "Imaging PD-L1 expression in melanoma brain metastases",
keywords = "Immune checkpoint therapy, brain metastases, metastases, positron emission tomography",
author = "Sridhar Nimmagadda",
note = "Funding Information: SN is supported by Allegheny Health Network-Johns Hopkins Cancer Research Fund, NIH 1R01CA236616, Funding Information: S.N. is a co-inventor on a pending U.S. patent covering PD-L1 imaging agents and as such are entitled to a portion of any licensing fees and royalties generated by the technology. This arrangement has been reviewed and approved by the Johns Hopkins University in accordance with its conflict-of-interest policies. S.N is a consultant for and receives funding from Precision Molecular Inc., Funding Information: SN is supported by Allegheny Health Network-Johns Hopkins Cancer Research Fund, NIH 1R01CA236616, and NIH P41EB024495.",
year = "2022",
month = jun,
day = "1",
doi = "10.2967/jnumed.121.263209",
language = "English (US)",
volume = "63",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "6",
}